About Progyny, Inc.
https://www.progyny.comProgyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
CEO
Peter Anevski CPA
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 190
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
BTIG
Buy
B of A Securities
Buy
Leerink Partners
Outperform
Keybanc
Overweight
Cantor Fitzgerald
Overweight
JP Morgan
Neutral
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:14.82M
Value:$387.02M
BLACKROCK INC.
Shares:11.82M
Value:$308.63M
VANGUARD GROUP INC
Shares:10.11M
Value:$263.97M
Summary
Showing Top 3 of 364
About Progyny, Inc.
https://www.progyny.comProgyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $313.35M ▼ | $51.31M ▼ | $13.86M ▼ | 4.42% ▼ | $0.16 ▼ | $25.23M ▼ |
| Q2-2025 | $332.87M ▲ | $54.62M ▲ | $17.11M ▲ | 5.14% ▲ | $0.2 ▲ | $28.28M ▲ |
| Q1-2025 | $324.04M ▲ | $51.63M ▲ | $15.06M ▲ | 4.65% ▲ | $0.18 ▲ | $25.28M ▲ |
| Q4-2024 | $298.43M ▲ | $47.65M ▲ | $10.53M ▲ | 3.53% ▼ | $0.12 | $16.66M ▲ |
| Q3-2024 | $286.63M | $46.79M | $10.42M | 3.64% | $0.12 | $13.29M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $345.21M ▲ | $795.23M ▲ | $235.22M ▼ | $560M ▲ |
| Q2-2025 | $305.09M ▲ | $760.95M ▲ | $245.93M ▼ | $515.02M ▲ |
| Q1-2025 | $256.12M ▲ | $730.28M ▲ | $263.13M ▲ | $467.16M ▲ |
| Q4-2024 | $227.95M ▼ | $607.1M ▼ | $185.04M ▼ | $422.06M ▼ |
| Q3-2024 | $235.72M | $659.97M | $225.1M | $434.88M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $13.86M ▼ | $47.58M ▼ | $-42.74M ▼ | $-2.4M ▼ | $1.48M ▼ | $42.9M ▼ |
| Q2-2025 | $17.11M ▲ | $55.51M ▲ | $-29.91M ▲ | $-2.33M ▲ | $23.3M ▲ | $50.24M ▲ |
| Q1-2025 | $15.06M ▲ | $49.81M ▼ | $-94.61M ▼ | $-3.29M ▲ | $-53.08M ▼ | $46.97M ▼ |
| Q4-2024 | $10.53M ▲ | $52.16M ▲ | $74.99M ▲ | $-56.33M ▲ | $70.83M ▲ | $50.27M ▲ |
| Q3-2024 | $10.42M | $44.52M | $15.36M | $-63.35M | $-3.48M | $42.72M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Fertility benefit services revenue | $380.00M ▲ | $210.00M ▼ | $210.00M ▲ | $200.00M ▼ |
 Pharmacy benefit services revenue | $220.00M ▲ | $120.00M ▼ | $120.00M ▲ | $110.00M ▼ |
CEO
Peter Anevski CPA
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 190
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
BTIG
Buy
B of A Securities
Buy
Leerink Partners
Outperform
Keybanc
Overweight
Cantor Fitzgerald
Overweight
JP Morgan
Neutral
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:14.82M
Value:$387.02M
BLACKROCK INC.
Shares:11.82M
Value:$308.63M
VANGUARD GROUP INC
Shares:10.11M
Value:$263.97M
Summary
Showing Top 3 of 364